Delivery Order SPE2DR25D2209-SPE2DR26FD6FQ
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,679.76 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 ml in D5W solution. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The delivery order was awarded...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,174.18 on August 13, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This firm fixed-price delivery order, valued at $1,686.34, represents a non-competitive set-aside order and is scheduled for completion by August 14, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a $2,094.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 1,000 mg/250 ml in D5W solution. This delivery order, issued on August 10, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive award for pharmaceutical medical supplies. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dobutamine 500 mg/250 mL in 5% dextrose solution with a ceiling value of $1,748.21. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W (dextrose 5% in water) solution. This order, valued at $3,004.49, was competitively awarded on August 15, 2025, with a completion date of August 18, 2025. The contract utilizes firm fixed pricing and is classified as a non-set-aside award. Performance will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.50 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract was competitively awarded with no set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 15, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve as the point of performance for this pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dobutamine 500 mg/250 ml in D5W solution. This firm fixed-price delivery order, valued at $2,139.28, is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's established capability to...
- The U.S. Department of Defense Medical Supply Chain has awarded a delivery order valued at $2,659.50 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500mg. The contract, awarded on September 25, 2025, with an ultimate completion date of October 23, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2024, for the supply of Dobutamine 500 mg/250 mL in D5W solution, with a contract value of $1,239.62 and ultimate completion date of November 5, 2024. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6FQDelivery Order
The Defense Logistics Agency awarded a $5,293.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W 250 mL on November 6, 2025, with an ultimate completion date of November 7, 2025. This competitively awarded contract, with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, continues to serve as a prime supplier for the Defense Logistics Agency's Medical Supply Chain through this and numerous other delivery orders. The company's federal contract portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical needs, including specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains. This delivery order for Dobutamine—a cardiovascular medication commonly used in military medical treatment facilities—reflects the company's ongoing role in ensuring pharmaceutical availability for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 11/6/25 |